参考文献:
40. FDA CDC ASM Sampling and Culturing Protocols 02 22 18. pdf; U.S. Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and American
Society for Microbiology (ASM), together with duodenoscope manufacturers and other experts [Internet]. FDA/CDC/ASM; 2018 [cited 2018 Mar 7].
Available at: https://www.fda.gov/ downloads/medicaldevices/productsandmedicalprocedures/
reprocessingofreusablemedicaldevices/ucm597949.pdf.
41. Weingarten RA, Johnson RC, Conlan S, et al. Genomic Analysis of hospital plumbing reveals diverse reservoir of bacterial plasmids conferring carbapenem resistance. mBio.
2018;9:e02011–e02017.
42. Verfaillie CJ, Bruno MJ, Voor in ’t Holt AF, et al. Withdrawal of a novel-design duodenoscope ends outbreak of a VIM-2-producing Pseudomonas aeruginosa. Endoscopy. 2015;47:493–502.
43. Jung M, Beilenhoff U. Hygiene: The Looming Achilles Heel in Endoscopy. Visc Med. 2016;32:21–28.
44. Ling ML, Ching P, Widitaputra A, et al. APSIC guidelines for disinfection and sterilization of instruments in health care facilities. Antimicrob Resist Infect Control. 2018;7:25.
45. Murdani A, Kumar A, Chiu H-M, et al. WEO position statement on hygiene in digestive endoscopy: Focus on endoscopy units in Asia and the Middle East. Dig Endosc. 2017;29:3–15.
46. Beilenhoff U, Neumann C, Rey J, et al. ESGE-ESGENA guideline for quality assurance in reprocessing: Microbiological surveillance testing in endoscopy. Endoscopy. 2007;39:175–181.
47. Chinese Society of Digestive Endoscopy. Consensus of experts on the safe operation of digestive endoscopy centers in China. J Dig Dis. 2016;17:790–799.
48. Roberts G, Roberts C, Jamieson A, et al. Surgery and obstetric care are highly cost-effective interventions in a Sub-Saharan African District Hospital: A Three-month single-institution study of surgical costs and outcomes. World J Surg. 2016;40: 14–20.
49. Rennert-May E, Conly J, Leal J, et al. Economic evaluations and their use in infection prevention and control: a narrative review. Antimicrob Resist Infect Control. 2018;7:31.
50. Bartsch SM, McKinnell JA, Mueller LE, et al. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2017;23:48.e9–48.e16.
51. Bardossy AC, Zervos J, Zervos M. Preventing hospitalacquired infections in low-income and middle-income countries. Infect Dis Clin North Am. 2016;30:805–818.
52. Griffiths H, Dwyer L. What every endoscopist should know about decontamination. Frontline Gastroenterol. 2019;10:167–170.
53. Association for the Advancement of Medical Instrumentation. Flexible and semi-rigid endoscope processing in health care facilities ANSI/AAMI ST91:2015 [Internet]. Arlington, VA:
Association for the Advancement of Medical Instrumentation; 2005. Available at: ANSI/AAMI ST91:2015 Flexible and semirigid endoscope processing
54. Preventing Device-Related Healthcare-Associated Infections [Internet]. “AAMI Guidelines. [cited 2018 Feb 7]. Available at: https://s3.amazonaws.com/rdcms-aami/files/production/public/FileDownloads/Summits/161227_AAMI_HAI_Forum_Report.pdf.
55. ISO 9000:2015(en), Quality management systems — Fundamentals and vocabulary [Internet]. [cited 2018 Jan 18]. Available at: https://www.iso.org/obp/ui/#iso:std:iso:9000:ed-4:v1:en.
56. ISO 9001:2015 - Quality management systems – Requirements [Internet]. [cited 2018 Jan 18]. Available at: https://www.iso.org/ standard/62085.html.
57. ISO 13485:2016 - Medical devices – Quality management systems – Requirements for regulatory purposes [Internet]. [cited 2018 Jan 18]. Available at: https://www.iso.org/standard/59752.html.
58. Beilenhoff U, Biering H, Blum R, et al. Prevention of multidrugresistant infections from contaminated duodenoscopes: Position Statement of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology Nurses and Associates (ESGENA). Endoscopy. 2017;49:1098–1106.
59. Kallen A FDA Meeting Transcript, Center for Devices and Radiological Health, Medical Devices Advisory Committee, Gastroenterology and Urology Devices Panel, May 14, 2015; A
Kallen, CDC Outbreak Investigation, page 199; Gastro05- 14-15.FINAL.pdf [Internet]. FDA; 2015 [cited 2018 Jun 3]. Available at: https://wayback.archive-it.org/7993/20170113091355/
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/Gastroenterology-UrologyDevicesPanel/UCM451164.pdf.
60. Centers for Disease Control and Prevention (CDC). Broncho scopy-related infections and pseudoinfections–New York, 1996 and 1998. MMWR Morb Mortal Wkly Rep. 1999;48:557–560.
61. Ren-Pei W, Hui-Jun X, Ke Q, et al. Correlation between the growth of bacterial biofilm in flexible endoscopes and endoscope reprocessing methods. Am J Infect Control. 2014;42:1203–1206.
62. Hervé RC, Keevil CW. Persistent residual contamination in endoscope channels; a fluorescence epimicroscopy study. Endoscopy. 2016;48:609–616.
63. Herrmann IF, Heeg P, Matteja B, et al. Risques et dangers cachés
de l’endoscopie, conduite à tenir. Acta Endosc. 2008;38:493–502.
64. Buss A, Been M, Borgers R, et al. Endoscope disinfection and its pitfalls – requirement for retrograde surveillance cultures. Endoscopy. 2008;40:327–332.
65. Kovaleva J, Meessen N, Peters F, et al. Is bacteriologic surveillance in endoscope reprocessing stringent enough? Endoscopy. 2009;41:913–916.
66. Johani K, Hu H, Santos L, et al. Determination of bacterial species present in biofilm contaminating the channels of clinical endoscopes. Infect Dis Health [Internet]. 2018;23:189–196.
67. Otter JA, Vickery K, Walker JT, et al. Surface-attached cells, biofilms and biocide susceptibility: implications for hospital cleaning and disinfection. J Hosp Infect. 2015;89:16–27.
68. Olson J FDA Meeting Transcript, Center for Devices and Radiological Health, Medical Devices Advisory Committee, Gastroenterology and Urology Devices Panel, May 14, 2015; J
Olson, page 69; Gastro05-14-15.FINAL.pdf [Internet]. FDA; 2015 [cited 2018 Jun 3]. Available at: https://wayback.archive-it. org/7993/20170113091355/
http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDe
vices/MedicalDevicesAdvisoryCommittee/GastroenterologyUrologyDevicesPanel/UCM451164.pdf`.
69. Bridier A, Briandet R, Thomas V, et al. Resistance of bacterial biofilms to disinfectants: a review. Biofouling. 2011;27:1017–1032.
70. Akinbobola AB, Sherry L, Mckay WG, et al. Tolerance of Pseudomonas aeruginosa in in-vitro biofilms to high-level peracetic acid disinfection. J Hosp Infect. 2017;97:162–168.
71. Ofstead CL, Wetzler HP, Johnson EA, et al. Simethicone residue remains inside gastrointestinal endoscopes despite reprocessing. Am J Infect Control. 2016;44:1237–1240.
72. Kola A, Piening B, Pape UF, et al. An outbreak of carbapenem-resistant OXA-48 - producing Klebsiella pneu monia associated to duodenoscopy. Antimicrob Resist Infect Control. 2015;4:8.
73. Ofstead CL, Heymann OL, Quick MR, et al. Residual moisture and waterborne pathogens inside flexible endoscopes: Evidence from a multisite study of endoscope drying effectiveness. Am J Infect Control. 2018;46:689–696.
74. Ofstead CL, Doyle EM, Eiland JE, et al. Practical toolkit for monitoring endoscope reprocessing effectiveness: Identification of viable bacteria on gastroscopes, colonoscopes, and broncho scopes. Am J Infect Control. 2016;44:815–819.
75. Ofstead CL, Wetzler HP, Eiland JE, et al. Assessing residual contamination and damage inside flexible endoscopes over time. Am J Infect Control. 2016;44:1675–1677.
76. Shenoy ES, Pierce VM, Walters MS, et al. Transmission of mobile colistin resistance (MCR-1) by duodenoscope. Clin Infect Dis. 2018;68:1327–1334.
77. Higa JT, Choe J, Tombs D, et al. Optimizing duodenoscope reprocessing: rigorous assessment of a culture and quarantine protocol. Gastrointest Endosc. 2018;88:223–229.
78. Petersen B. Other considerations: Perspective and obligations of our societies and governmental organizations. Tech Gastrointest Endosc. 2019;21:150609.
79. Thaker AM, Muthusamy VR, Sedarat A, et al. Duodenoscope reprocessing practice patterns in U.S. endoscopy centers: a survey study. Gastrointest Endosc. 2018;88:316–322.
80. Kovaleva J. Endoscope drying and its pitfalls. J Hosp Infect. 2017;97:319–328.
81. Alfa MJ, Sitter DL. In-hospital evaluation of contamination of duodenoscopes: a quantitative assessment of the effect of drying. J Hosp Infect. 1991;19:89–98.
82. Petersen BT. Duodenoscope reprocessing: risk and options coming into view. Gastrointest Endosc. 2015;82: 484–487.
83. Barakat MT, Huang RJ, Banerjee S. Comparison of automated and manual drying in the eliminating residual endoscope working channel fluid after reprocessing (with video). Gastro
intest Endosc. 2018;89:124–132.
84. AORN, Burlingame B, Conner R. Guidelines for Perioperative Practice. AORN. Incorporated. 2017:919.
85. Saliou P, Le Bars H, Payan C, et al. Measures to improve microbial quality surveillance of gastrointestinal endoscopes. Endoscopy. 2016;48:704–710.
86. Perumpail RB, Marya NB, McGinty BL, et al. Endoscope reprocessing: Comparison of drying effectiveness and microbial levels with an automated drying and storage cabinet with forced filtered air and a standard storage cabinet. Am J Infect Control. 2019;47: 1083–1086.